Home
Company
  • About Us
  • Vision & Mission
  • History
  • Intellectual Property
  • Management Board
  • Supervisory Board
  • Advisory Board
  • Contact Us
Pipeline
  • Biosimilars
  • Biosimilar Pipeline
  • FYB201
  • FYB202
  • FYB203
  • FYB206
  • FYB207 (COVID-19)
Investors
  • Shares
  • Facts & Figures
  • News Distributor
  • Financial Reports
  • Calendar
  • Annual General Meeting
  • Corporate Governance
  • Ad Hoc Announcements
News
  • Press Releases
  • Archive
  • Downloads
Careers
  • Why Formycon
  • Your Benefits
  • Job Offers
DE EN
Loading...

Archives Publications

Half-Year-Report 2023

Half-Year-Report 2023

Half-Year-Report 2023

by Formycon AG

Annual Report 2022

Annual Report 2022

by Formycon AG

Half-Year-Report 2022

Half-Year-Report 2022

by Formycon AG

Annual Report 2021

Annual Report 2021

by Formycon AG

Half-Year-Report 2021

Half-Year-Report 2021

by Formycon AG

Annual Report 2020

Annual Report 2020

by Formycon AG

Half-Year-Report 2020

Half-Year-Report 2020

by Formycon AG

Annual Report 2019

Annual Report 2019

by Formycon AG

Half-Year-Report 2019

Half-Year-Report 2019

by Formycon AG

Annual Report 2018

Annual Report 2018

by Formycon AG

  • 1
  • 2
  • 3
Company
About Us Vision & Mission History Intellectual Property Management Board Supervisory Board Advisory Board
News
Press Releases Downloads
Pipeline
Biosimilars Biosimilar Pipeline FYB201 FYB202 FYB203 FYB206 FYB207 (COVID-19)
Career
Why Formycon Your Benefits Job Offers
Investors
Facts & Figures News Distributor Financial Reports Calendar Annual General Meeting 2022 Corporate Governance Ad Hoc Announcements
Contact
Location & Approach Contact Persons
Social
Twitter XING LinkedIn
Member of Bio Deutschland Member of Medicines for Europe Member of UN Global Compact

We will keep you up to date!

News Distributor Subscription
Formycon AG
Global Quality Biosimilars

© Formycon AG

Legal Notice Data Protection